UNSPSC 51281617: Micronomicin

This classification denotes an aminoglycoside antibiotic with the molecular formula C20H41N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S9AZ0R40QV, chemically known as o-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-a-d-erythro-hexopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->6))-2-deoxy-d-streptamine but generally known as micronomicin, which bears US NIH Compound Identifier 107677.

UNSPSC 51281617 Micronomicin is a Commodity code that in practice captures state and local procurement of pharmaceutical products and related medical supplies, though the recent opportunities demonstrate a broader scope than the code name alone suggests. State and local health departments and county health authorities use this code to source antibiotics, opioid-reversal agents, and drug-disposal systems for public health and emergency response programs. The Illinois Department of Public Health and Seminole County, Florida represent the issuing-body mix, spanning state health departments and county health agencies. Procurements under this code typically bundle multiple pharmaceutical line items or medical supplies into single contracts with initial terms of 12 to 24 months and renewal options, and are awarded through competitive bid processes such as ITB or IFB with fixed pricing on a per-unit basis.

Recent activity appears concentrated in the South and Midwest. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse cooperative purchasing consortium to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets, totaling $2,999,999.11 over the three-year contract life including renewal periods. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, though the due date listed (July 26, 2023) predates the posting and suggests a data-quality anomaly. Both procurements require vendors to manage shipping and delivery logistics and comply with drug-free workplace and E-Verify requirements. The code shows limited recent solicitation activity; the two opportunities identified span different product categories (antibiotics versus naloxone and drug-disposal systems) and do not align tightly with the code's nominal scope, signaling potential misclassification or narrow use of this code by issuing bodies.